Role of poly(ADP-ribose) polymerase-1 (PARP-1) in the inflammatory response

Inmunologia

Volumn 21, Issue 4, 2002, Pages 219-227

  Yelamos J ^a   Oliver, F J ^b  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

Author keywords

Inflammation; Poly (ADP ribose) polymerase 1; Transcription

Indexed keywords

3 AMINOBENZAMIDE; CYTOKINE; DNA; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; ISOQUINOLINE DERIVATIVE; NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; NITRIC OXIDE SYNTHASE; PYRONE DERIVATIVE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DNA DAMAGE; DNA PROTEIN COMPLEX; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HEMORRHAGIC SHOCK; INFLAMMATION; INFLAMMATORY DISEASE; ISCHEMIA; MOUSE; NONHUMAN; PROTEIN PROTEIN INTERACTION; REPERFUSION INJURY; REVIEW; SEPTIC SHOCK; TRANSCRIPTION REGULATION;

EID: 0036824682     PISSN: 02139626     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (81)

1. Hawiger J. Innate immunity and inflammation: a transcriptional paradigm. Immunol Res 2001; 23: 99-109.
2. Heine H, Ulmer AJ, Flad HD, Hauschildt S. Lipopolysaccharide-induced change of phosphorylation of two cytosolic proteins in human monocytes is prevented by inhibitors of ADP-ribosylation. J Immunol 1995; 155: 4899-908.
3. Le Page C, Pellat-Deceunynck C, Drapier JC, Wietzerbin J. Effects of inhibitors of ADP-ribosylation on macrophage activation. Adv Exp Med Biol 1997; 419: 203-7.
4. Wang ZQ, Auer B, Stingl L, Berghammer H, Haidacher D, Schweiger M, et al. Mice lacking ADPRT and poly (ADP-ribosyl)ation develop normally but are susceptible to skin disease. Genes Dev 1995; 9: 509-20.
5. Menissier de Murcia J, Niedergang C, Trucco C, Ricoul M, Dutrillaux B, Mark M, et al. Requirement of poly (ADP-ribose) polymerase in recovery from DNA damage in mice and in cells. Proc Natl Acad Sci USA 1997; 94: 7303-7.
6. Shall S, de Murcia G. Poly (ADP-ribose) polymerase-1: what have we learned from the deficient mouse model? Mutat Res 2000; 460: 1-15.
7. de Murcia G, and Menissier de Murcia J. Poly (ADP-ribose) polymerase: a molecular nick-sensor. Trends Biochem Sci 1994; 19: 172-6.
8. Smith S. The world according to PARP. Trends Biochem Sci 2001; 26: 174-9.
9. Satoh MS, Poirier GG, Lindahl T. Dual effect for poly (ADP-ribose) synthesis in response to DNA strand breakage. Biochemistry 1994; 33: 7099-106.
10. Lin W, Ame JC, Aboul-Ela N, Jacobson EL, Jacobson MK. Isolation and characterization of the cDNA encoding bovine poly (ADP-ribose)-glycohydrolase. J Biol Chem 1997; 272: 11895-901.
11. Homburg S, Visochek L, Moran N, Dantzer F, Priel E, Asculai E, et al. A fast signal-induced activation of poly (ADP-ribose) polymerase: a novel downstream target of phospholipase C. J Cell Biol 2000; 150: 293-307.
12. Shall S. ADP-ribosylation of proteins: a ubiquitous cellular control mechanism. Biochem Soc Trans 1989; 17: 317-2.
13. Gradwohl G, Menissier de Murcia J, Molinete M, Simonin F, Koken M, Hoeijmakers JH, et al. The second zinc-finger domain of poly (ADP-ribose) polymerase determines specificity for single-stranded breaks in DNA. Proc Natl Acad Sci USA 1990; 87: 2990-4.
14. de Murcia G, Schreiber V, Molinete M, Saulier B, Poch O, Masson M, et al. Structure and function of poly(ADP-ribose) polymerase. Mol Cell Biochem 1994; 138: 15-24.
15. Wang ZQ, Stingl L, Morrison C, Jantsch M, Los M, Schulze-Osthoff K, et al. PARP is important for genomic stability but dispensable in apoptosis. Genes Dev 1997; 11: 2347-58.
16. -/- cell line expressing PARP-1 DNA-binding domain. Biochem Biophys Res Commun 2001; 285: 289-94.
17. Morrison C, Smith GC, Stingl L, Jackson SP, Wagner EF, Wang AQ. Genetic interaction between PARP and DNA-PK in V(D)J recombination and tumorigenesis. Nat Genet 1997; 17: 479-82.
18. Oliver FJ, de la Rubia G, Rolli V, Ruiz-Ruiz MC, de Murcia G, Menissier de Murcia J. Importance of poly (ADP-ribose) polymerase and its cleavage in apoptosis. Lesson from an uncleavable mutant. J Biol Chem 1998; 273: 33533-9.
19. -/- cell line transfected with PARP DNA-binding domain mutants. J Mol Biol 1999; 290: 943-9.
20. Yu S, Wang H, Poitras MF, Coombs C, Bowers WJ, Federoff HJ, et al. Mediation of Poly (ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 2002; 297: 259-63.
21. d'Adda di Fagagna F, Hande MP, Tong WM, Lansdorp PM, Wang ZQ, Jackson SP. Functions of poly (ADP-ribose) polymerase in controlling telomere length and chromosomal stability. Nat Genet 1999; 23: 76-80.
22. Oei SL, Griesenbeck J, Schweiger M, Ziegler M. Regulation of RNA polymerase II-dependent transcription by poly (ADP-ribosyl)ation of transcription factors. J Biol Chem 1998; 273: 31644-7.
23. Eliasson MJL, Sampei K, Mandir AS, Hurn PD, Traystman RJ, Bao J, et al. Poly (ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat Med 1997; 3: 1089-95.
24. Thiemermann C, Bowes J, Myint FP, Vane JR. Inhibition of the activity of poly (ADP-ribose) synthetase reduces ischemia-reperfusion injury in the heart and skeletal muscle. Proc Natl Acad Sci USA 1997; 94: 679-83.
25. Zingarelli B, Cuzzocrea S, Zsengellér ZS, Salzman AL, Szabó C. Protection against myocardial ischemia and reperfusion injury by 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase. Cardiovasc Res 1997; 36: 205-15.
26. Ducrocp S, Benjelloun N, Plotkine M, Ben-Ari Y, Charriaut-Marlangue C. Poly (ADP-ribose) synthase inhibition reduces ischemic injury and inflammation in neonatal rat brain. J Neurochem 2000; 74: 2504-11.
27. Chatterjee PK, Zacharowski K, Cuzzocrea S, Otto M, Thiemermann C. Inhibitors of poly (ADP-ribose) synthetase reduce renal ischemia-reperfusion injury in the anesthetized rat in vivo. FASEB J 2000; 14: 641-51.
28. Liaudet L, Szabó A, Soriano FG, Zingarelli B, Szabó C, Salzman AL. Poly (ADP-ribose) synthetase mediates intestinal mucosal barrier dysfunction after mesenteric ischemia. Shock 2000; 14: 134-41.
29. Chiang SK, Lam TT. Post-treatment at 12 or 18 hours with 3-aminobenzamide ameliorates retinal ischemia-reperfusion damage. Invest Ophthalmol Vis Sci 2000; 41: 3210-14.
30. Khandoga A, Enders G, Biberthaler P, Krombach F. Poly (ADP-ribose) polymerase triggers the microvascular mechanisms of hepatic ischemia-reperfusion injury. Am J Physiol Gastrointest Liver Physiol 2002; 283: G553-60.
31. Cuzzocrea S, Mazzon E, Sautebin L, Dugo L, Serraino I, De Sarro A, et al. Effects of 5-aminoisoquinolinone, a water-soluble, potent inhibitor of the activity of poly (ADP-ribose) polymerase, in a rodent model of lung injury. Biochem Pharmacol 2002; 63: 293-304.
32. Szabó G, Bährle S, Stumpf N, Sonnenberg K, Szabó E, Pacher P, et al. Poly (ADP-ribose) polymerase inhibition reduces reperfusion injury after heart transplantation. Cir Res 2002; 90: 100-6.
33. Pacher P, Liaudet L, Mabley J, Komjati K, Szabo C. Pharmacologic inhibition of poly (adenosine diphosphate-ribose) polymerase may represent a novel therapeutic approach in chronic heart failure. J Am Coll Cardiol 2002; 40: 1006-16.
34. Liaudet L, García Soriano F, Szabó E, Virág L, Mabley JG, Salzman AL, et al. Protection against hemorrhagic shock in mice genetically deficient in poly (ADP-ribose) polymerase. Proc Natl Acad Sci USA 2000; 97: 10203-8.
35. Watts JA, Grattan RM, Whitlow BS, Kline JA. Activation of poly (ADP-ribose) polymerase in severe hemorrhagic shock and resuscitation. Am J Physiol Gastrointest liver Physiol 2001; 281: G498-506.
36. Parrillo JE. Pathogenetic mechanism of septic shock. N Engl J Med 1993; 328: 1471-7.
37. Ghosh S, May MJ, Kopp EB. NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998; 16: 225-60.
38. Oliver FJ, Menissier de Murcia, Nacci C, Decker P, Andriantsitohaina R, Muller S, et al. Resistance to endotoxic shock as a consequence of defective NF-κB activation in poly (ADP-ribose) polimerase-1 deficient mice. EMBO J 1999; 18: 4446-54.
39. Kühnle S, Nicotera P, Wendel A, Leist M. Prevention of endotoxin-induced lethality, but not of liver apoptosis in poly (ADP-ribose) polymerase-deficient mice. Biochem Biophys Res Commun 1999; 263: 433-8.
40. Li P, Allen H, Banerjee S, Franklin S, Herzog L, Johnston C, et al. Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock. Cell 1995; 80: 401-11.
41. Marino MW, Dunn A, Grail D, Inglese M, Noguchi Y, Richards E, et al. Characterization of tumor necrosis factor-deficient mice. Proc Natl Acad sci USA 1997; 94: 8093-8.
42. Burkart V, Wang ZQ, Radons J, Heller B, Herceg Z, Stingl L, et al. Mice lacking the poly (ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozocin. Nat Med 1999; 5: 314-9.
43. Pieper AA, Brat DJ, Krug DK, Watkins CC, Gupta A, Blackshaw S, et al. Poly (ADP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes. Proc Natl Acad Sci USA 1999; 96: 3059-64.
44. Masutani M, Suzuki H, Kamada N, Watanabe M, Ueda O, Nozaki, et al. Poly (ADP-ribose) polymerase gene disruption conferred mice resistant to streptozotocin-induced diabetes. Proc Natl Acad Sci USA 1999; 96: 2301-4.
45. Akiyama T, Takasawa S, Nata K, Kobayashi S, Abe M, Shervani NJ, et al. Activation of Reg gene, a gene for insulin-producing b-cell regeneration: poly (ADP-ribose) polymerase binds Reg promoter and regulates the transcription by autopoly(ADP-ribosyl)ation. Proc Natl Acad Sci USA 2001; 98: 48-53.
46. González C, Menissier de Murcia J, Bidouard JP, Beauvais C, et al. Unexpected sensitivity of nonobese diabetic mice with a disrupted poly (ADP-ribose) polymerase-1 gene to streptozotocin-induced and spontaneous diabetes. Diabetes 2002; 51: 1470-6.
47. Soriano FG, Virag L, Jagtap P, Szabó E, Mabley JG, Liaudet L, et al. Diabetic endothelial dysfunction: the role of poly (ADP-ribose) polymerase activation. Nat Med 2001; 7: 108-13.
48. Soriano FG, Pacher P, Mabley J, Liaudet L, Szabo C. Rapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of poly (ADP-ribose) polymerase. Circ Res 2001; 89: 684-91.
49. Szabó C, Virag L, Cuzzocrea S, Scott GS, Hake P, O'Connor MP, et al. Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly (ADP-ribose) synthase. Proc Natl Acad Sci USA 1998; 95: 3867-72.
50. Jijon HB, Churchill T, Malfair D, Wessler A, Jewell LD, Parsons HG, et al. Inhibition of poly (ADP-ribose) polymerase attenuates inflammation in a model of chronic colitis. Am J Physiol Gastrointes Liver Physiol 20051.
51. Yamamoto H, Uchigata Y, Okamoto H. Streptozotocin and alloxan induce DNA strand breaks and poly (ADP-ribose) synthetase in pancreatic islets. Nature 1981; 294: 284-6.
52. Szabo C, Zingarelli B, O'Connor M, Salzman AL. DNA strand breakage, activation of poly (ADP-ribose) synthetase and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite. Proc Natl Acad Sci USA 1996; 93: 1753-8.
53. Szabo C, Cuzzocrea S, Zingarelli B, O'Connor M, Salzman AL. Endothelial dysfunction in a rat model of endotoxic shock. Importance of the activation of poly (ADP-ribose) synthetase by peroxynitrite. J Clin Invest 1997; 100: 723-35.
54. Szabo C, Dawson VL. Role of poly (ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. Trends Pharmacol Sci 1998; 19: 287-98.
55. Chiarugi A. Poly(ADP-ribose) polymerase: killer or conspirator? The "suicide hypothesis" revisited. Trends Pharmacol Sci 2002; 23: 122-9.
56. Ziegler M, Oei SL. A cellular survival switch: poly (ADP-ribosyl)ation stimulates DNA repair and silences transcription. BioEssay 2001; 23: 543-8.
57. Rawling JM, Álvarez-González R. TFIIF, a basal eukaryotic transcription factor, is a substrate for poly(ADP-ribosyl)ation. Biochem J 1997; 324: 249-53.
58. Butler AJ, Ordahl CP. Poly (ADP-ribose) polymerase binds with transcription enhancer factor 1 to MCAT1 elements to regulate muscle-specific transcription. Mol Cell Biol 1999; 19: 296-306.
59. Anderson MG, Scoggin KE, Simbulan-Rosenthal CM, Steadman JA. Identification of poly (ADP-ribose) polymerase as a transcriptional coactivator of the human T-cell leukemia virus type 1 Tax protein. J Virol 2000; 74: 2169-77.
60. Kannan P, Yu Y, Wankhade S, Tainsky MA. Poly ADP-ribose polymerase is a coactivator for AP-2-mediated transcriptional activation. Nucleic Acids Res 1999; 27: 866-74.
61. Cervellera MN, Sala A. Poly (ADP-ribose) polymerase is a B-MYB coactivator. J Biol Chem 2000; 275: 10692-96.
62. Nie J, Sakamoto S, Song D, Qu Z, Ota K, Taniguchi T. Interaction of Oct-1 and automodification domain of poly(ADP-ribose) synthetase. FEBS Lett 1998; 424: 27-32.
63. Oei SL, Griesenbeck J, Schweiger M, Babich V, Kropotov A, Tomilin N. Interaction of the transcription factor YY1 with human poly (ADP-ribosyl) transferase. Biochem Biophys Res Commun 1997; 240: 108-11.
64. Hasssa PO, Hottiger MO. A role of poly (ADP-ribose) polymerase in NF-κB transcriptional activation. Biol Chem 1999; 380: 953-9.
65. Nirodi C, NagDas S, Gygi SP, Olson G, Aebersold R, Richmond A. A role for poly (ADP-ribose) polymerase in the transcriptional regulation of the melanoma growth stimulatory activity (CXCL1) gene expression. J Biol Chem 2001; 276: 9366-74.
66. Soldatenkow VA, Chasovskikh S, Potaman VN, Trofimova I, Smulson ME, Dritschilo A. Transcriptional repression by binding of poly (ADP-ribose) polymerase to promoter sequences. J Biol Chem 2002; 277: 665-70.
67. Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu Rev Immunol 2000; 18: 621-63.
68. Hassa PO, Covic M, Hasan S, Imhof R, Hottiger MO. The enzymatic and DNA binding activity of PARP-1 are not required for NF-κB coactivator function. J Biol Chem 2001; 276: 45588-97.
69. Virag L, Szabo C. The therapeutic potential of poly (ADP-ribose) polymerase inhibitors. Pharmacol Rev 2002; 54: 375-429.
70. Banasik M, Komura H, Shimoyama M, Ueda K. Specific inhibitors of poly (ADP-ribose) synthetase and mono (ADP-ribosyl) transferase. J Biol Chem 1992; 267: 1569-75.
71. White AW, Almassy R, Calvert AH, Curtin NJ, Griffin RJ, Hostomsky Z, et al. Resistance-modifying agents. 9. Synthesis and biological properties of benzimidazole inhibitors of the DNA repair enzyme poly (ADP-ribose) polymerase. J Med Chem 2000; 43: 4084-97.
72. Zhang J, Lautar S, Huang S, Ramsey C, Cheung A, Li JH. GPI 6150 prevents H(2)O(2) cytotoxicity by inhibiting poly (ADP-ribose) polymerase. Biochem Biophys Res Commun 2000; 278: 590-8.
73. Jagtap P, Soriano FG, Virag L, Liaudet L, Mabley J, Szabo E, et al. Novel phenanthridinone inhibitors of poly (adenosine 5′ diphosphate-ribose) synthetase: Potent cytoprotective and antishock agens. Crit Care Med 2002; 30: 1071-82.
74. Ha HC, Hester LD, Snyder SH. Poly (ADP-ribose) polymerase-1 dependence of stress-induced transcription factors and associated gene expression in glia. Proc Natl acad Sci USA 2002; 99: 3270-75.
75. Ame JC, Rolli V, Schreiber V, Niedergang C, Apiou F, Decker P, et al. PARP-2, a novel mammalian DNA damage-dependent poly (ADP-ribose) polymerase. J Biol Chem 1999; 274: 17860-68.
76. Johansson M. A human poly(ADP-ribose) polymerase gene family (ADPRTL): cDNA cloning of two novel poly (ADP-ribose) polymerase homologues. Genomics. 1999; 57: 442-5.
77. Smith S, de Lange T. Tankyrase promotes telomere elongation in human cells. Curr Biol 2000; 10: 1299-302.
78. Chi NW, Lodish HE Tankyrase is a Golgi-associated MAP kinase substrate that interacts with IRAP in GLUT4 vesicles. J Biol Chem 2000; 275: 38437-44.
79. Lyons RJ, Deane R, Lynch DK, Ye ZS, Sanderson GM, Eyre HJ, et al. Identification of a novel human tankyrase through its interaction with the adaptor protein Grb14. J Biol Chem 2001; 276: 17172-80.
80. Kaminker PG, Kim SH, Taylor RD, Zebarjadian Y, Funk WD, Morin GB, et al. TANK2, a new TRF1-associated poly (ADP-ribose) polymerase, causes rapid induction of cell death upon overexpression. J Biol Chem 2001; 276: 35891-9.
81. Kickhoefer VA, Siva AC, Kedersha NL, Inman EM, Ruland C, Streuli M, et al. The 193-kD vault protein, VPARP, is a novel poly (ADP-ribose) polymerase. J Cell Biol 1999; 146: 917-28.